SOFMEDICA is expanding in Croatia

SOFMEDICA, a renowned regional healthcare solutions provider in Central and Southeastern Europe, is thrilled to announce the inauguration of its business in Croatia, marking a pivotal moment in the company’s relentless pursuit of growth and commitment to delivering groundbreaking solutions in New Europe . This strategic move follows the successful entry into the Hungarian market two years ago, reflecting its momentum and mission to make cutting-edge solutions accessible to as many Croatian patients as possible.

This strategic expansion underscores SOFMEDICA’s dedication to strengthening its 29-year legacy presence in SEE while making available the flagship technology from its portfolio, the daVinci Robotic Surgery , available to as many Croatian patients as possible.

There are over 8,000 daVinci Robotic Surgery programs worldwide, and the introduction of this groundbreaking technology in Croatia represents a significant milestone. Croatian patients will now have the opportunity toaccess this life-saving innovation, which offers many benefits to the patients, such as minimize blood loss and complications, faster recovery, and a shorter hospital stay, ultimately enhancing the overall patient experience.

Croatia, with its strategic location and EU member status, holds immense potential for growth. With a population of over four million people, it offers a dynamic market for investment and development. According to the European Commission, the country has been witnessing steady GDP growth, estimated up to 1.6% in 2023 and 2.3% in 2024, making it an attractive destination for businesses. While healthcare expenditure is rising, there’s room for further investment in healthcare infrastructure, especially in addressing the prevalence of cancer and heart-related health issues, which pose significant opportunities for healthcare innovation and improvement.

“The launching of da Vinci surgery in Croatia is a testament to our unwavering dedication to advancing life-saving technologies and providing the most efficient clinical solutions to healthcare professionals in New Europe. Every patient’s life is paramount to us, and we are determined to make innovative technologies accessible even to the remotest patients in our region. This strategic move will enable us to extend our reach to new geographical areas, enhancing existing diagnostics and treatment procedures for life-threatening conditions,” declared Harris Palaondas, Business Director of SOFMEDICA.

As an integral aspect of its commitment to the Croatian market, SOFMEDICA will offer an exclusive range of cutting-edge medical technologies focused on Oncology, Heart Pathologies, and Brain Neurology, complemented by comprehensive clinical and technical assistance. Furthermore, it is establishing the needed infrastructure to nurture the growth and expertise of local healthcare professionals, investing in the future health and well-being of the local community. In this endeavour, the ISLE ACADEMY (Innovation, Simulation, Learning Ecosystem) will play a pivotal role in nurturing the professional development of local healthcare experts, ensuring they stay at the forefront of medical advancements.

SOFMEDICA is committed to upholding global healthcare compliance standards, ensuring quality and safe practices in all its solutions, by offering a reliable and risk-free partnership for Croatia’s healthcare requirements, driven by a shared vision of a healthier, more promising future for all.

“It is with a mixed sense of exhilaration and responsibility to enter the Croatian Healthcare market. Our North Star will be to enable Croatian healthcare professionals with proven, cutting-edge technology and continuous education to achieve superior patient outcomes,” says Evangelos Kalamakis, Managing Director, SOFMEDICA.

SOFMEDICA – Life-Saving Innovation is a member of SOFMEDICA Group, an education-oriented Group of Companies focused on healthcare, operating in Europe (Romania, Greece, Bulgaria, Cyprus, Hungary, Croatia) since 1994 aiming at the creation of sustainable, improved clinical outcomes for patients in European countries SOFMEDICA deploys its activities through a team of 160 mission-oriented professionals and is expected to report an annual turnover of approximately €60 million in 2023.